Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Small fiber neuropathy: a disabling and underrecognized syndrome

Voortman, Mareyea,b; Fritz, Daanc; Vogels, Oscar J.M.d; Eftimov, Filipc; van de Beek, Diederikc; Brouwer, Matthijs C.c; Drent, Marjoleina,e

Current Opinion in Pulmonary Medicine: September 2017 - Volume 23 - Issue 5 - p 447–457
doi: 10.1097/MCP.0000000000000413
SARCOIDOSIS: Edited by Robert P. Baughman and Marcel Veltkamp

Purpose of review To discuss cause, clinical manifestations, diagnostics, and treatment of small fiber neuropathy (SFN). The diagnosis is difficult and can be easily missed.

Recent findings SFN causes high morbidity with disabling symptoms and impact on quality of life. Patients may benefit from being diagnosed with SFN, even if no underlying cause is identified and no specific treatment is yet available. Recently, genetic mutations as a possible cause of SFN were identified. Clinical diagnostic criteria have been proposed, but no gold standard exists, and each test has its limitations. The diagnosis requires a combination of typical symptoms, abnormal neurologic findings, and absence of large fiber involvement. Clinicians should be aware of overlapping symptoms of SFN and fibromyalgia. Treatment is often difficult, even when the underlying cause is identified and appropriately treated. Usually, only symptomatic relief of complaints is available.

Summary Awareness of SFN and related symptoms is of great clinical relevance. Guidelines for appropriate diagnostic workup using a stepwise approach involving a combination of tests are warranted. Even if no treatment is available, patients may benefit from timely recognition of SFN.

aDepartment of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein

bDivision of Heart & Lungs, Department of Pulmonology, University Medical Centre Utrecht, Utrecht

cDepartment of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam Neuroscience, Amsterdam

dDepartment of Neurology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein

eDepartment of Pharmacology and Toxicology, FHML, Maastricht University, Maastricht, The Netherlands

Correspondence to Mareye Voortman, MD, Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, PO Box 2400, 3430 VB Nieuwegein, The Netherlands. Tel: +31 887574379; fax: +31 681151868; e-mail: m.voortman@antoniusziekenhuis.nl

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.